Response to Pederson et al. and Chlebowski et al.

被引：0

作者：

Cold, Soren ^{[1
,7
]}

Cold, Frederik ^{[1
]}

Jensen, Maj-Britt ^{[2
]}

Cronin-Fenton, Deirdre ^{[3
,4
]}

Christiansen, Peer ^{[5
]}

Ejlertsen, Bent ^{[2
,6
]}

机构：

[1] Odense Univ Hosp, Dept Oncol, Odense, Denmark

[2] Copenhagen Univ Hosp, Danish Breast Canc Grp, Rigshosp, Copenhagen, Denmark

[3] Aarhus Univ, Clin Inst, Dept Clin Epidemiol, Aarhus, Denmark

[4] Aarhus Univ Hosp, Aarhus, Denmark

[5] Aarhus Univ Hosp, Dept Plast & Breast Surg, Aarhus, Denmark

[6] Copenhagen Univ Hosp, Dept Oncol, Rigshosp, Copenhagen, Denmark

[7] Odense Univ Hosp, Dept Oncol, Klovervaenget 13B, DK-5000 Odense, Denmark

来源：

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE | 2023年 / 115卷 / 02期

关键词：

D O I：

10.1093/jnci/djac214

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：229 / 230

页数：2

共 7 条

[1]

Chlebowski RT, 2023, JNCI-J NATL CANCER I, V115, P222, DOI 10.1093/jnci/djac213

[2] Danish Breast Cancer Cooperative Group [J].

Christiansen, Peer ;

Ejlertsen, Bent ;

Jensen, Maj-Britt ;

Mouridsen, Henning .

CLINICAL EPIDEMIOLOGY, 2016, 8 :445-449

[3] Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials [J].

Dowsett, M. ;

Forbes, J. F. ;

Bradley, R. ;

Ingle, J. ;

Aihara, T. ;

Bliss, J. ;

Boccardo, F. ;

Coates, A. ;

Coombes, R. C. ;

Cuzick, J. ;

Dubsky, P. ;

Gnant, M. ;

Kaufmann, M. ;

Kilburn, L. ;

Perrone, F. ;

Rea, D. ;

Thuerlimann, B. ;

van de Velde, C. ;

Pan, H. ;

Peto, R. ;

Davies, C. ;

Gray, R. ;

Baum, M. ;

Buzdar, A. ;

Sestak, I. ;

Markopoulos, C. ;

Fesl, C. ;

Jakesz, R. ;

Colleoni, M. ;

Gelber, R. ;

Regan, M. ;

von Minckwitz, G. ;

Snowdon, C. ;

Goss, P. ;

Pritchard, K. ;

Anderson, S. ;

Costantino, J. ;

Mamounas, E. ;

Ohashi, Y. ;

Watanabe, T. ;

Bastiaannet, E. .

LANCET, 2015, 386 (10001) :1341-1352

[4] Excess mortality in postmenopausal high-risk women who only receive adjuvant endocrine therapy for estrogen receptor positive breast cancer [J].

Ejlertsen, Bent ;

Jensen, Maj-Britt ;

Mouridsen, Henning T. .

ACTA ONCOLOGICA, 2014, 53 (02) :174-185

[5] PAM50 Risk of Recurrence Score Predicts 10-Year Distant Recurrence in a Comprehensive Danish Cohort of Postmenopausal Women Allocated to 5 Years of Endocrine Therapy for Hormone Receptor-Positive Early Breast Cancer [J].

Laenkholm, Anne-Vibeke ;

Jensen, Maj-Britt ;

Eriksen, Jens Ole ;

Rasmussen, Birgitte Bruun ;

Knoop, Ann S. ;

Buckingham, Wesley ;

Ferree, Sean ;

Schaper, Carl ;

Nielsen, Torsten O. ;

Haffner, Taryn ;

Kibol, Torben ;

Talman, Maj-Lis Moller ;

Jylling, Anne Marie Bak ;

Tabor, Tomasz Piotr ;

Ejlertsen, Bent .

JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (08) :735-+

[6] RE: Systemic or vaginal hormone therapy after early breast cancer: a Danish observational cohort study [J].

Pederson, Holly J. ;

Faubion, Stephanie S. ;

Pruthi, Sandhya ;

Goldfarb, Shari .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2023, 115 (02) :220-221

[7] Data Resource Profile: The Danish National Prescription Registry [J].

Pottegard, Anton ;

Schmidt, Sigrun Alba Johannesdottir ;

Wallach-Kildemoes, Helle ;

Sorensen, Henrik Toft ;

Hallas, Jesper ;

Schmidt, Morten .

INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2017, 46 (03) :798-+

← 1 →